Physician profile
Patrick J Riggins
NPI 1386687184
$1,021.29
in general payments reported to CMS, 2019-2025
26 companies · $283 in 2025
The $283 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $113 · 2020: $96.06 · 2021: $149 · 2022: $65.54 · 2023: $75.85 · 2024: $239 · 2025: $283.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $597.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $597.38 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Djo, LLC | $112.11 | 2021-2025 | Cmf |
| Pacira Therapeutics, INC. | $107.66 | 2019-2021 | |
| Heron Therapeutics, INC. | $88.83 | 2025 | Zynrelef |
| Stryker Corporation | $83.54 | 2024-2025 | Tritanium, Mako, Infinity Adaptis |
| Vertex Pharmaceuticals Incorporated | $76.65 | 2024-2025 | |
| Bioventus LLC | $59.52 | 2019-2021 | |
| Ferring Pharmaceuticals INC. | $56.36 | 2019-2022 | |
| Convatec INC. | $50.10 | 2019-2022 | |
| Boston Scientific Corporation | $49.98 | 2024-2025 | Wavewriter Alpha Prime 16 |
| Pacira Pharmaceuticals Incorporated | $35.79 | 2024 | Zilretta, Iovera |
| Radius Health, INC. | $35.73 | 2021 | |
| Globus Medical, INC. | $32.59 | 2025 | Senza |
| Abbvie INC. | $30.02 | 2022-2023 | Dalvance |
| Amgen INC. | $24.07 | 2019 | |
| Si-Bone, INC. | $23.49 | 2025 |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Integra Lifesciences Corporation | $19.39 | 2024 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Organogenesis INC. | $16.81 | 2023 | Puraply |
| Endo USA, INC. | $15.67 | 2025 | Xiaflex |
| Nevro Corp. | $15.56 | 2024 | Senza |
| Fidia Pharma USA INC. | $15.21 | 2022 | |
| Linvatec Corporation | $15.01 | 2023 | Linvatec Extremities, Biobrace 23mm |
| Assertio Therapeutics, INC. | $14.76 | 2019 | |
| Endo Pharmaceuticals INC. | $14.55 | 2021 | |
| Zyla Life Sciences, INC. | $13.23 | 2020 | |
| Biocomposites INC | $8.73 | 2023 | Stimulan |
| Skeletal Dynamics INC | $5.93 | 2024 | Align, Implate, Geminus |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Patrick Riggins listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.